Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flukicidal effects of abietane diterpenoid derived analogues against the food borne pathogen Fasciola hepatica.
Chakroborty A, Pritchard D, Bouillon ME, Cervi A, Cookson A, Wild C, Fenn C, Payne J, Holdsworth P, Capner C, O'Neill J, Padalino G, Forde-Thomas J, Gupta S, Smith BG, Fisher M, Lahmann M, Baird MS, Hoffmann KF. Chakroborty A, et al. Among authors: fenn c. Vet Parasitol. 2022 Sep;309:109766. doi: 10.1016/j.vetpar.2022.109766. Epub 2022 Jul 20. Vet Parasitol. 2022. PMID: 35926239 Free article.
An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
Whiteland HL, Chakroborty A, Forde-Thomas JE, Crusco A, Cookson A, Hollinshead J, Fenn CA, Bartholomew B, Holdsworth PA, Fisher M, Nash RJ, Hoffmann KF. Whiteland HL, et al. Among authors: fenn ca. Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):465-474. doi: 10.1016/j.ijpddr.2018.10.009. Epub 2018 Oct 26. Int J Parasitol Drugs Drug Resist. 2018. PMID: 30399512 Free PMC article.
Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica.
Chakroborty A, Pritchard DR, Bouillon ME, Cervi A, Kraehenbuehl R, Wild C, Fenn C, Holdsworth P, Capner C, Padalino G, Forde-Thomas JE, Payne J, Smith BG, Fisher M, Lahmann M, Baird MS, Hoffmann KF. Chakroborty A, et al. Among authors: fenn c. Pharmaceutics. 2023 Jul 3;15(7):1869. doi: 10.3390/pharmaceutics15071869. Pharmaceutics. 2023. PMID: 37514055 Free PMC article.
Plastic physicians: The surgical salamanders of the COVID-19 pandemic.
Hughes BA, Hassan S, Stallard J, Louette S, Smith J, Knight SL, Fenn C, Peach H, Thornton DJ, Hernon C, Goodenough J, Bhat W, West CC, Bains RD, Bourke G, Smith IM, Liddington MI. Hughes BA, et al. Among authors: fenn c. J Plast Reconstr Aesthet Surg. 2021 Feb;74(2):401-406. doi: 10.1016/j.bjps.2020.08.122. Epub 2020 Sep 20. J Plast Reconstr Aesthet Surg. 2021. PMID: 33097434 Free PMC article.
22q11.2 microdeletion and increased risk for type 2 diabetes.
Van L, Heung T, Malecki SL, Fenn C, Tyrer A, Sanches M, Chow EWC, Boot E, Corral M, Dash S, George SR, Bassett AS. Van L, et al. Among authors: fenn c. EClinicalMedicine. 2020 Sep 10;26:100528. doi: 10.1016/j.eclinm.2020.100528. eCollection 2020 Sep. EClinicalMedicine. 2020. PMID: 33089125 Free PMC article.
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study.
Potter S, Conroy EJ, Cutress RI, Williamson PR, Whisker L, Thrush S, Skillman J, Barnes NLP, Mylvaganam S, Teasdale E, Jain A, Gardiner MD, Blazeby JM, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative. Potter S, et al. Lancet Oncol. 2019 Feb;20(2):254-266. doi: 10.1016/S1470-2045(18)30781-2. Epub 2019 Jan 9. Lancet Oncol. 2019. PMID: 30639093 Free PMC article.
63 results